A systems-level scientific analysis examining the in vitro receptor kinetics and biochemical pathways of Semax.

A precise molecular and tissue-specific investigation of Semax signaling kinetics and cellular responses in vitro.

An in-depth, systems-level preclinical research synthesis of Semax’s regulation of BDNF and TrkB tyrosine kinase activation in hippocampal cultures.

An analytical research synthesis of Semax-mediated regulation of BDNF and TrkB tyrosine kinase activation in hippocampal neuronal cultures.

Neurotrophic Transcription: Semax Regulation of BDNF and TrkB Tyrosine Kinase Activation in Hippocampal Cultures

← Back to The Cognitive Edge Neurotrophic Transcription: Semax Regulation of BDNF and TrkB Tyrosine Kinase Activation in Hippocampal Cultures Section 1: Compound Overview Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide derived from the adrenocorticotropin fragment ACTH(4–10). The parent sequence, shared across several melanocortin analogs, lacks adrenocorticotropic hormonal activity but retains significant central nervous system bioactivity. […]

Semax is a synthetic heptapeptide analog derived from the adrenocorticotropic hormone fragment ACTH(4-10), with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro.

This analysis reviews rodent-model literature on Semax and the upregulation of BDNF and NGF expression without direct TrkB receptor binding.

Dissecting Semax’s central melanocortin receptor MC4R binding mechanisms and its downstream neurotrophic effects via the BDNF-TrkB transcription pathway.

An exploration of the ACTH(4-10) analog Semax, focusing on TrkB receptor phosphorylation kinetics and transcriptomic upregulation of BDNF.